We partner with physicians, scientists and researchers around the world to better understand human health. Together, we can reduce the cost and improve the efficiency of treating patients with rare genetic disorders. Our process of providing individualized treatment options can be broken down into four steps:
When we receive your contact form, we’ll get in touch and set up a call to talk through the potential ways we can use our expertise to help you make sense of the genetic variant data. We collaborate with you to create a scope of work that delivers the answers you need.
After we agreed on the scope of the project, it’s time for planning and information exchange. During this stage, we’ll discuss additional background information about the patient’s history, phenotypic presentation, and genotypes in order to prepare for the next step.
We create the Patient Avatar, a unique animal model of the patient’s variants, and thoroughly characterize its biology. Then we treat with a select set of therapeutics and look again to see how the drug affected the animal’s behavior and underlying biology.
We provide you with a comprehensive set of findings, including key takeaways about variant status, function, mechanism of action, and therapeutic response. The data we provide gives you better insight serve your patient with better outcomes.
WHAT WE DO
Where Whole Genome Sequencing (WGS) ends, we begin.
Sequencing information gives context to the phenotypes you see in the clinic, but sometimes sequencing data just results in more questions. We offer an in-vivo platform for the functional analysis of variants that yields data for assessment of patient-specific treatment options.